MedPath

MIDOL MULTI-SYMPTOM CAPLETS EXTRA STRENGTH

MIDOL MULTI-SYMPTOM CAPLETS EXTRA STRENGTH

Discontinued
DIN Number

02150484

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

bayer inc consumer care

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02150484
AIG Number0324673001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.92
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETAMINOPHENActive
Strength: 500 MG / TAB
Monograph: ACETAMINOPHEN
CAFFEINEActive
Strength: 60 MG / TAB
Monograph: CAFFEINE
PYRILAMINE MALEATEActive
Strength: 15 MG / TAB
Monograph: PYRILAMINE MALEATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.